24.01

4.94% 1.13

After Hours: 24.05 0.04 +0.17%

Sutro Biopharma Inc (STRO)

Overview News Price History Option Chain Financials Discussions Forecast

Sutro Biopharma Inc stock is traded at $24.01, with a volume of 220.40K. It is up +4.94% in the last 24 hours and down -21.33% over the past month. Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Previous Close:

$22.88

Open:

$22.98

24h Volume:

220.40K

Relative Volume:

0.63

Market Cap:

$397.86M

Revenue:

$99.61M

Net Income/Loss:

$-153.60M

P/E Ratio:

-1.4598

EPS:

-16.4479

Net Cash Flow:

$-152.14M

1W Performance:

+6.29%

1M Performance:

-21.33%

6M Performance:

+44.46%

1Y Performance:

+170.63%

1-Day Range:

$22.98

$24.35

1-Week Range:

$21.72

$24.92

52-Week Range:

$7.15

$43.85

Sutro Biopharma Inc Stock (STRO) Company Profile

Name

Sutro Biopharma Inc

Sector

Healthcare (1074)

Industry

Biotechnology (599)

Phone

650-392-8412

Address

111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA

Employee

133

Twitter

@SutroBio

Next Earnings Date

2026-08-06

Latest SEC Filings

STRO's Discussions on Twitter

Compare STRO vs VRTX, REGN, ARGX, RVMD, ALNY

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STRO Sutro Biopharma Inc	24.01	379.13M	99.61M	-153.60M	-152.14M	-16.45
VRTX Vertex Pharmaceuticals Inc	479.00	121.16B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	667.17	68.78B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	888.82	57.44B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	188.07	40.23B	742.00K	-1.37B	-1.07B	-7.0731
ALNY Alnylam Pharmaceuticals Inc	278.40	36.28B	4.29B	577.22M	641.34M	4.2086

Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-07-26	Initiated	Leerink Partners	Outperform
Mar-24-26	Upgrade	H.C. Wainwright	Neutral → Buy
Mar-24-26	Upgrade	Wells Fargo	Equal Weight → Overweight
Jan-20-26	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform
Jun-16-25	Upgrade	Piper Sandler	Neutral → Overweight
Mar-17-25	Downgrade	H.C. Wainwright	Buy → Neutral
Mar-14-25	Downgrade	BofA Securities	Buy → Underperform
Mar-14-25	Downgrade	Citizens JMP	Mkt Outperform → Mkt Perform
Mar-14-25	Downgrade	Wedbush	Outperform → Neutral
May-08-24	Initiated	BofA Securities	Buy
Nov-09-23	Initiated	Deutsche Bank	Buy
Oct-06-23	Initiated	Oppenheimer	Outperform
Mar-21-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Aug-18-22	Resumed	Wells Fargo	Overweight
Jun-18-21	Initiated	H.C. Wainwright	Buy
Dec-03-20	Initiated	Stifel	Buy
Sep-02-20	Initiated	Jefferies	Buy
Jul-16-20	Initiated	Wells Fargo	Overweight
Jan-13-20	Initiated	SunTrust	Buy
Oct-07-19	Initiated	BTIG Research	Buy
Jul-18-19	Initiated	Deutsche Bank	Buy
Apr-29-19	Initiated	H.C. Wainwright	Buy
Oct-22-18	Initiated	JMP Securities	Mkt Outperform
Oct-22-18	Initiated	Piper Jaffray	Overweight
Oct-22-18	Initiated	Wedbush	Outperform

View All

Sutro Biopharma Inc Stock (STRO) Latest News

Jul 27, 2026